Calf slimming injections:
muscle bulk or fat, and what botulinum toxin in the gastrocnemius changes

What are calf slimming injections, and which muscle do they treat?

Calf slimming injections use botulinum toxin to reduce the bulk of the gastrocnemius. The gastrocnemius is the superficial calf muscle with two heads, one on the inner side and one on the outer, which start above the knee and merge into the Achilles tendon. It is the muscle that stands out when you rise onto your toes, and its inner head is usually the larger and the one people notice from behind and from the side. Beneath it lies the soleus, a flatter, deeper muscle that does most of the work of standing and walking and is not a target.

Botulinum toxin blocks the release of acetylcholine at the junction between nerve and muscle, so the injected fibres contract less. A muscle that is recruited less is slowly remodelled and loses some mass, which is why the change is gradual and why it is temporary: nerve endings re-establish their connections, the muscle is used again and it rebuilds. The principle is the one used for the masseter and the upper trapezius; the gastrocnemius is simply larger and has a job that cannot be paused.

That job is the reason the treatment is planned conservatively. The gastrocnemius lifts the heel on every stride, powers a jump, and is the muscle that fires when you climb stairs or stand on tiptoe to reach a shelf. Weakening it changes how those tasks feel for as long as the medicine acts, so the dose is set to the muscle volume with a margin for function, and people whose sport or work depends on calf power are usually steered away from it.

Is it muscle or fat? How the calf is assessed on tiptoe

A thick calf has three common authors and the examination separates them. The person stands flat, then rises onto the toes, then walks a few steps, and the calf is pinched at its widest point in each position.

• Muscle. On tiptoe the gastrocnemius contracts into a hard, defined mass, the calf changes shape markedly, and a pinch at the widest point picks up only a thin layer of skin and fat over a firm muscle. The widest point sits high, near the top third of the lower leg. This is the finding that suits injections, and it is common in people who walk a great deal, climb stairs daily, wear heels, dance or run.
• Fat. The calf looks similar flat and on tiptoe, the pinch picks up a soft fold that moves independently of the muscle, and the thickness continues lower toward the ankle. Fat is not a toxin question; it is assessed for the clinic's body treatments, in the same way as the thigh.
• Bone and tendon. A short Achilles tendon with a low-lying muscle belly, a wide tibia or a thick ankle set the outline before muscle or fat is added. Nothing injected changes them, and recognising this early saves a person from a treatment that cannot answer the concern.

Most calves are a mixture, and the assessment estimates how much of the width is muscle. The two legs are compared, because the dominant leg is often larger, and the inner and outer heads are compared, because the inner head usually carries more of the bulk. Where the soleus rather than the gastrocnemius dominates the width, which shows as a calf that stays broad low down even when the person is flat-footed and relaxed, injections into the gastrocnemius will not change the outline, and the soleus is not treated because of its role in standing.

“If the calf looks the same flat and on tiptoe, the width is not the muscle, and no injection into the muscle will change it.”

Dr Sin YongOn the tiptoe test

What changes with calf injections, and what does not?

What can change is the bulk of the treated heads of the gastrocnemius, gradually, as the muscle is recruited less; where muscle is the main author of the width, the aim is a softer curve at the top of the calf. The change is judged at review in the same standing and tiptoe positions as the assessment photographs, not in the mirror soon after.

What does not change is a longer list and it is worth reading before booking an assessment. Fat over the calf stays as it was. The soleus beneath, which is not treated, continues to set the lower outline. Bone, tendon and the ankle are unchanged, so a calf that is wide because the tibia is wide or the Achilles is short will look much the same. Skin does not tighten. The definition that appears on tiptoe is reduced, which is the aim for some people and a loss for others, and that preference is asked about directly. The change is temporary: as nerve endings recover and the muscle is used again, bulk returns, and someone who wants to keep the outline has to plan for maintenance and be told honestly what that means.

A point that is often missed is that the gastrocnemius responds to how it is used after treatment. A person who continues to train the calves hard, run hills or wear high heels daily is loading a muscle that is being asked to rest, and the bulk rebuilds sooner. The habits that built the muscle are part of the plan, and that conversation happens at assessment rather than at review.

Walking, exercise and daily life after calf injections

Walking on flat ground is not prevented, because the soleus and the untreated fibres carry it. What people notice, for as long as the medicine acts, is that the calf tires more quickly on stairs, on slopes and on tiptoe, that a long day on foot feels longer, and that pushing off at the start of a run or a jump has less spring. In heels the calf works harder than it does flat, so heels can feel more tiring than before. These effects are expected, they are the mechanism showing itself, and they are the reason the dose is conservative at a first treatment.

Straight afterwards the injected areas are left alone: no massage, no hot baths or saunas, and no heavy calf training until the review. Gentle walking is encouraged. Running, jumping sports, dance and climbing are paused rather than attempted, because a muscle that is being quietened does not protect the ankle and the Achilles tendon as well as it did, and a strain in that window is avoidable. A return to those activities is planned at the review according to how the calf feels, not on a fixed schedule.

Driving, standing at work and ordinary household activity are unaffected for most people. Anyone who feels unsteady on the feet, who develops weakness in the thigh or the other leg, or who has difficulty swallowing, breathing or speaking should contact the clinic the same day, because those are signs the medicine has acted further than intended.

Who suits calf slimming injections, and who should not have them?

The table sets out the findings that make gastrocnemius botulinum toxin a reasonable discussion and the findings that close it or route it elsewhere.

Side effects are those of any injection, tenderness, bruising and a dull ache in the muscle, plus the functional effects described above: early fatigue on stairs and tiptoe, less spring, and, if placement drifts or the dose is generous, a feeling of unsteadiness. Asymmetry between legs is avoided by treating each to its own finding rather than to the same number. Uncommon risks include infection at an injection site, an allergic reaction, and reduced response with repeated treatment of large muscles.

How this concern is approached at the clinic, and what decides the plan

Whether calf botulinum toxin is offered for a particular person is confirmed at consultation, after Dr Sin Yong has examined the legs in person: flat, on tiptoe, walking and with the pinch test described above. Every treatment on this site is doctor-performed after an in-person assessment, and a plan is not written from photographs. When the width is fat rather than muscle, the person is told so and the conversation moves to the body page; when it is bone or tendon, the person is told that too.

Once the muscle is the author, the plan is decided by a short list of factors. The volume of each head of the gastrocnemius on each leg sets the dose and the number of points, and the inner head usually takes more. The difference between legs decides whether they are treated differently. What the person does on their feet, in work and in sport, sets how much function must be kept and can rule the treatment out. The record of any botulinum toxin used elsewhere, with the product, dose and date, matters because units differ between formulations. Fees are set in writing after assessment, and the reasoning is on how fees are quoted.

Where it is offered, mapping is done by hand: the person stands on tiptoe, the borders and the thickest point of each head are felt and marked, the marks are photographed, and the dose is divided across several points through the belly of the muscle, into the muscle rather than the fat above it and away from the back of the knee, where vessels and nerves run close to the surface. The review compares the same positions and the same photographs, and any top-up is decided there rather than in advance.